Pancreatic Cancer section

Prostate Cancer News & Features

Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer

Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer

Hypofractionated regimen of precision radiotherapy was not inferior to conventional RT in patients with intermediate-risk prostate cancer.

Fluciclovine PET/CT Improves Targeted Radiation Treatment of Recurrent Prostate Cancer

Fluciclovine PET/CT Improves Targeted Radiation Treatment of Recurrent Prostate Cancer

F-18-fluciclovine PET helps detect and localize recurrent prostate cancer allowing for individualized, targeted therapy.

Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer

Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer

A single 19-Gy fraction of brachytherapy was found as effective as a longer regimen of low-dose-rate brachytherapy in localized prostate cancer.

Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer

Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer

Cabozantinib activated innate immunity and completely eradicated prostate cancer in a study using a mouse model.

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

Shorter course of higher dose radiation therapy provide effective treatment, costs less, and is easier on patients than current standard radiation therapy course.

No Association Between Vasectomy and Prostate Cancer Risk

No Association Between Vasectomy and Prostate Cancer Risk

There is no association between vasectomy and the risk of overall, high-grade, or advanced-stage prostate cancer or prostate cancer-related mortality.

Low-Fat Meal May Allow for Lower Doses of Abiraterone Acetate in Prostate Cancer Patients

Low-Fat Meal May Allow for Lower Doses of Abiraterone Acetate in Prostate Cancer Patients

A lower dose of abiraterone acetate with a low fat meal may have the same effect as taking the standard dose as recommended on an empty stomach.

Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure

Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure

Treatment expectations of individuals with metastatic prostate cancer and their health care providers often do not match.

Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer

Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer

African American men choosing active surveillance for their low-grade prostate cancer have overall poorer health than non-African American men undergoing active surveillance.

Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals

Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals

A significant difference exists in the failure to follow-up rates among patients undergoing active surveillance at university-based hospitals versus safety-net hospitals.

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs